Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsDoxorubicin

doxorubicin

Biotechnology

FDA Approves Genentech’s Polivy in Combination With R-CHP for People With Certain Types of Previously Untreated Diffuse Large B-cell Lymphoma

Business Wire -
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Polivy in combination with Rituxan, cyclophosphamide,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us